Ionotropic Glutamate Receptors in Hypothalamic Paraventricular and Supraoptic Nuclei Mediate Vasopressin and Oxytocin Release in Unanesthetized Rats

Página do item simplificado
dc.contributor.authorBusnardo, Cristiane
dc.contributor.authorCrestani, Carlos Cesar [UNESP]
dc.contributor.authorResstel, Leonardo B. M.
dc.contributor.authorTavares, Rodrigo F.
dc.contributor.authorAntunes-Rodrigues, Jose
dc.contributor.authorCorrea, Fernando M. A.
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T15:34:46Z
dc.date.available2014-05-20T15:34:46Z
dc.date.issued2012-05-01
dc.description.abstractWe report changes in plasma arginine vasopressin (AVP) and oxytocin (OT) concentrations evoked by the microinjection of L-glutamate (L-glu) into the hypothalamic supraoptic nucleus (SON) and paraventricular nucleus(PVN) of unanesthetized rats, as well as which local mechanisms are involved in their mediation. L-Glu microinjection (10 nmol/100 nl) into the SON increased the circulating levels of both AVP and OT. The AVP increases were blocked by local pretreatment with the selective non-N-methyl-D-aspartate (NMDA) receptor antagonist 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) (2 nmol/100 nl), but it was not affected by pretreatment with the NMDA-receptor antagonist LY235959 (2 nmol/100 nl). The OT response to L-glu microinjection into the SON was blocked by local pretreatment with either NBQX or LY235959. Furthermore, the administration of either the non-NMDA receptor agonist (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid hydrobromide (AMPA) (5 nmol/100 nl) or NMDA receptor agonist NMDA (5 nmol/100 nl) into the SON had no effect on OT baseline plasma levels, but when both agonists were microinjected together these levels were increased. L-Glu microinjection into the PVN did not change circulating levels of either AVP or OT. However, after local pretreatment with LY235959, the L-glu microinjection increased plasma levels of the hormones. The L-glu microinjection into the PVN after the local treatment with NBQX did not affect the circulating AVP and OT levels. Therefore, results suggest the AVP release from the SON is mediated by activation of non-NMDA glutamate receptors, whereas the OT release from this nucleus is mediated by an interaction of NMDA and non-NMDA receptors. The present study also suggests an inhibitory role for NMDA receptors in the PVN on the release of AVP and OT. (Endocrinology 153: 2323-2331, 2012)en
dc.description.affiliationUniv São Paulo, Dept Pharmacol, Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil
dc.description.affiliationUniv São Paulo, Dept Physiol, Sch Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil
dc.description.affiliationSão Paulo State Univ, Dept Nat Act Principles & Toxicol, Sch Pharmaceut Sci, Univ Estadual Paulista Julio de Mesquita Filho, BR-01049010 São Paulo, Brazil
dc.description.affiliationUnespSão Paulo State Univ, Dept Nat Act Principles & Toxicol, Sch Pharmaceut Sci, Univ Estadual Paulista Julio de Mesquita Filho, BR-01049010 São Paulo, Brazil
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipIdFAPESP: 09/05308-8
dc.description.sponsorshipIdCNPq: 505394/2003-0
dc.description.sponsorshipIdCNPq: 305996/2008-8
dc.description.sponsorshipIdCNPq: 480550/2007-7
dc.format.extent2323-2331
dc.identifierhttp://dx.doi.org/10.1210/en.2011-2079
dc.identifier.citationEndocrinology. Chevy Chase: Endocrine Soc, v. 153, n. 5, p. 2323-2331, 2012.
dc.identifier.doi10.1210/en.2011-2079
dc.identifier.fileWOS000303860700030.pdf
dc.identifier.issn0013-7227
dc.identifier.lattes1117432571971568
dc.identifier.urihttp://hdl.handle.net/11449/42642
dc.identifier.wosWOS:000303860700030
dc.language.isoeng
dc.publisherEndocrine Soc
dc.relation.ispartofEndocrinology
dc.relation.ispartofjcr3.961
dc.relation.ispartofsjr1,878
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.titleIonotropic Glutamate Receptors in Hypothalamic Paraventricular and Supraoptic Nuclei Mediate Vasopressin and Oxytocin Release in Unanesthetized Ratsen
dc.typeArtigo
dcterms.licensehttps://www.endocrine.org/endocrine-press/copyright-permissions
dcterms.rightsHolderEndocrine Soc
unesp.author.lattes1117432571971568[2]
unesp.author.orcid0000-0002-1942-858X[2]
unesp.author.orcid0000-0003-4067-9524[6]
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Ciências Farmacêuticas, Araraquarapt

Arquivos

Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
WOS000303860700030.pdf
Tamanho:
521.55 KB
Formato:
Adobe Portable Document Format
Baixar
Licença do Pacote
Agora exibindo 1 - 2 de 2
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição:

Coleções

Artigos - Princípios Ativos Naturais e Toxicologia - FCFAR